Table 1.
Patient characteristics.
| Patient characteristics | Expressed as | |||
|---|---|---|---|---|
| Demographic characteristics | ||||
| Sex | ||||
| Female | Frequency | 2 (22.2%) | ||
| Male | Frequency | 7 (77.8%) | ||
| Age (years) | Mean ± SD | 60.8 ± 6.9 | ||
| Length (cm) | Mean ± SD | 175.8 ± 9.3 | ||
| Weight (kg) | Mean ± SD | 85.2 ± 15.4 | ||
| BMI (kg/m2) | Mean ± SD | 27.5 ± 4.9 | ||
| Clinical characteristics | Timepoints | |||
| Screening | Timepoint 1 | Timepoint 2 | ||
| Systolic blood pressure (mmHg) | Mean ± SD | 137.1 ± 14.6 | N.A. | N.A. |
| Diastolic blood pressure (mmHg) | Mean ± SD | 80.4 ± 8.8 | N.A. | N.A. |
| qSOFA score | Median (range) | 0 (0–1) | N.A. | N.A. |
| Respiratory rate | Mean ± SD | 20.8 ± 3.3 | 20.8 ± 3.3 | 18.9 ± 2.2 |
| Duration of illness | Mean ± SD | 9.0 ± 2.9 | 9.1 ± 2.9 | 11.8 ± 3.4 |
| Supplemental oxygen volume (L/min) | Mean ± SD | 4.1 ± 3.4 | 4.4 ± 3.5 | 4.6 ± 5.2 |
| Type of supplemental oxygen | ||||
| Nasal cannula | Frequency | 7 (77.8%) | 6 (66.7%) | 6 (66.7%) |
| Venturi mask (40%) | Frequency | 0 (0%) | 1 (11.1%) | 2 (22.2%) |
| Venturi mask (60%) | Frequency | 2 (22.2%) | 2 (22.2%) | 0 (0%) |
| Non-rebreathing mask | Frequency | 0 (0%) | 0 (0.0%) | 0 (0%) |
| High-flow nasal cannula/Non-invasive ventilation mask | Frequency | 0 (0%) | 0 (0%) | 1 (11.1%) |
| Mechanical ventilation | Frequency | 0 (0%) | 0 (0%) | 0 (0%) |
| Comedications during hospitalization | ||||
| Remdesivir | Frequency | 5 (55.6%) | ||
| Anakinra | Frequency | 1 (11.1%) | ||
| Tocilizumab | Frequency | 1 (11.1%) | ||
| Baricitinib | Frequency | 1 (11.1%) | ||
| Clinical outcome | ||||
| Length of hospital stay (days) | Mean ± SD | 8.8 ± 3.6 | ||
| Required ICU admission | Frequency | 0 (0%) | ||
| In-hospital mortality | Frequency | 0 (0%) | ||